Transgenic Research

, Volume 15, Issue 6, pp 673–686 | Cite as

Advances in transgenic rat production

Original Paper

Abstract

Predictable and reproducible production of transgenic rats from a standardized input of egg donors and egg recipients is essential for routine rat model production. In the course of establishing a transgenic rat service, transgenic founders were produced from three transgenes in outbred Sprague-Dawley (SD) rats and four transgenes in inbred Fischer 344 (F344) rats. Key parameters that affect transgenesis efficiency were assessed, including superovulation treatments, methods to prepare pseudopregnant recipients, and microinjection technique. Five superovulation regimens were compared and treatment with 20 IU PMSG and 30 IU HCG was selected for routine use. Four methods to prepare pseudopregnant egg recipients were compared and estrus synchronization with LHRHa and mating to vasectomized males was selected as most effective. More than 80% of eggs survived microinjection when modified pronuclear microinjection needles and DNA buffers were used. The efficiencies of transgenic production in rats and C57BL/6J (B6J) mice were compared to provide a context for assessing the difficulty of transgenic rat production. Compared to B6J mice, SD rat transgenesis required fewer egg donors per founder, fewer pseudopregnant egg recipients per founder, and produced more founders per eggs microinjected. Similar numbers of injection days were required to produce founders. These results suggest that SD rat transgenesis can be more efficient than B6J mouse transgenesis with the appropriate technical refinements. Advances in transgenic rat production have the potential to increase access to rat models.

Keywords

Transgenic rats Sprague-Dawley rats Fischer 344 rats Superovulation C57BL/6 transgenic mice Transgenic efficiency Microinjection 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

Acknowledgments

We thank Colin Bishop, Yuji Ikeno, Sean Morrison, R. Scott Turner, Robert Thompson, and Roger Wiggins for providing transgenes and genotyping. We thank Tina Hutchinson and Corey Ziebell for their help managing the rat colonies and Maggie Van Keuren for C57BL/6J microinjection data. We thank Anne Rouleau for advice on mechanical stimulation. T.S. thanks Joe Warren for introducing him to the making of transgenic rats. Support was received from NIH grants CA46592, AR20557, DK34933, and AG013283. Additional support was provided by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000815).

References

  1. Armstrong DT, Opavsky MA (1988) Superovulation of immature rats by continuous infusion of follicle-stimulating hormone. Biol Reprod 39:511–518PubMedCrossRefGoogle Scholar
  2. Auerbach AB, Norinsky R, Ho W, Losos K, Guo Q, Chatterjee S, Joyner AL (2003) Strain-dependent differences in the efficiency of transgenic mouse production. Transgenic Res 12:59–69PubMedCrossRefGoogle Scholar
  3. Breban M, Hacquard-Bouder C, Falgarone G (2004) Animal models of HLA-B27-associated diseases. Curr Mol Med 4:31–40PubMedCrossRefGoogle Scholar
  4. Brinster RL, Chen HY, Trumbauer ME, Yagle MK, Palmiter RD (1985) Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc Natl Acad Sci (USA) 82:4438–4442CrossRefGoogle Scholar
  5. Charreau B, Tesson L, Buscail J, Soulillou JP, Anegon I (1996a) Analysis of human CD59 tissue expression directed by the CMV-IE-1 promoter in transgenic rats. Transgenic Res 5:443–50CrossRefGoogle Scholar
  6. Charreau B., Tesson L, Soulillou JP, Pourcel C, Anegon I (1996b) Transgenic rats: Technical aspects and models. Transgenic Res 5:223–234CrossRefGoogle Scholar
  7. Collidge TA, Lammie GA, Fleming S, Mullins JJ (2004) The role of the renin–angiotensin system in malignant vascular injury affecting the systemic and cerebral circulations. Prog Biophys Mol Biol 84:301–319PubMedCrossRefGoogle Scholar
  8. Corbin TJ, McCabe JG (2002) Strain variation of immature female rats in response to various superovulatory hormone preparations and routes of administration. Contemp Topics 41:18–23Google Scholar
  9. Cornejo-Cortes MA, Sanchez-Torres C, Vazquez-Chagoyan JS, Suarez-Gomez HM, Garrido-Farina G, Meraz-Rios MA (2006) Rat embryo quality and production efficiency are dependent on gonatdotrophin dose in superovulatory treatments. Lab Animals 40:87–95CrossRefGoogle Scholar
  10. Dahl LK, Heine M, Tassinari L (1962) Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature 194:480–2PubMedCrossRefGoogle Scholar
  11. Dycaico MJ, Provost GS, Kretz PL, Ransom SL, Moores JC, Short JM (1994) The use of shuttle vectors for mutation analysis in transgenic mice and rats. Mutat Res 307:461–78PubMedGoogle Scholar
  12. Egwuagu CE, Sztein J, Mahdi RM, Li W, Chao-Chan C, Smith JA, Charukamnoetkanok P, Chepelinsky AB (1999) IFN-gamma increases the severity and accelerates the onset of experimental autoimmune uveitis in transgenic rats. J Immunol 162:510–517PubMedGoogle Scholar
  13. Heideman J (1991) Transgenic rats: a discussion. Biotechnology 16:325–333PubMedGoogle Scholar
  14. Henderson KM, Weaver A, Wards RL, Ball K, Lun S, Mullin C, McNatty KP (1990) Oocyte production and ovarian steroid concentrations of immature rats in response to some commercial gonadotrophin preparations. Reprod Fertil Dev 2:671–682PubMedCrossRefGoogle Scholar
  15. Hirabayashi M, Ito K, Sekimoto A, Hochi S, Ueda M (2001) Production of transgenic rats using young Sprague-Dawley females treated with PMSG and hCG. Exp Anim 50:365–369PubMedCrossRefGoogle Scholar
  16. Hirabayashi M, Kato M, Ishikawa A, Kaneko R, Yagi T, Hochi S (2005) Factors affecting production of transgenic rats by ICSI-mediated DNA transfer: effects of sonication and freeze-thawing of spermatozoa, rat strains for sperm and oocyte donors, and different constructs of exogenous DNA. Mol Repro Dev 70:422–428CrossRefGoogle Scholar
  17. Hochi S, Ninomiya T, Honman M, Yuki A (1991) Successful production of transgenic rats. Anim Biotech 1:175–184Google Scholar
  18. Iannaccone P, Galat V (2002) Production of transgenic rats. In: Pinkert CA (ed) Transgenic animal technology. Academic Press, New York, (pp.235–250)Google Scholar
  19. Ishigame H, Medan MS, Watanabe G, Shi Z, Kish H, Arai KY, Taya K (2004) A new alternative method for superovulation using passive immunization against inhibin in adult rats. Biol Reprod 71:236–243PubMedCrossRefGoogle Scholar
  20. Kisseberth WC, Brettingen NT, Lohse JK, Sandgren EP (1999) Ubiquitous expression of marker transgenes in mice and rats. Dev Biol 214: 128–138PubMedCrossRefGoogle Scholar
  21. Kon H, Tohei A, Hokao R, Shinoda M (2005) Estrous cycle stage-independent treatment of PMSG and hCG can induce superovulation in adult Wistar-Imamichi rats. Exp Anim 54:185–187PubMedCrossRefGoogle Scholar
  22. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D (2002) Germline Transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295:868–872PubMedCrossRefGoogle Scholar
  23. Long JA, Evans HM (1922) The Oestrous Cycle in the rat and its associated phenomena. University of California Press, BerkeleyGoogle Scholar
  24. Maurer RA, Erwin CR, Donelson JE (1981) Analysis of 5′ flanking sequences and intron-exon boundaries of the rat prolactin gene. J Biol Chem 256:10524–10528PubMedGoogle Scholar
  25. Michalkiewicz M, Michalkiewicz T (2000) Developing transgenic neuropeptide Y rats. Methods Mol Biol 153:73–89PubMedGoogle Scholar
  26. Mukumoto S, Mori S, Ishikawa H (1995) Efficient induction of superovulation in adult rats by PMSG and HCG. Exp Anim 44:111–118PubMedCrossRefGoogle Scholar
  27. Pfeifer A (2004) Lentiviral transgenesis. Transgenic Res 13:513–522PubMedCrossRefGoogle Scholar
  28. Popova E, Krivokharchenko A, Ganten D, Bader M (2002) Comparison between PMSG- and FSH- induced superovulation for the generation of transgenic rats. Mol Reprod Dev 63:177–182PubMedCrossRefGoogle Scholar
  29. Popova E, Bader M, Krivokharchenko A (2005) Strain differences in superovulatory response, embryo development and efficiency of transgenic rat production. Transgenic Res 14:729–738PubMedCrossRefGoogle Scholar
  30. Ramos SD, Lee JM, Peuler JD (2001) An inexpensive meter to measure differences in electrical resistance in the rat vagina during the ovarian cycle. J Appl Physiol 91:667–670PubMedGoogle Scholar
  31. Rouleau AMJ, Kovacs PR, Kunz HW, Armstrong DT (1993) Decontamination of rat embryos and transfer to specific pathogen-free recipients for the production of a breeding colony. Lab Animal Sci 43:611–615Google Scholar
  32. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer- directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491PubMedCrossRefGoogle Scholar
  33. Sato Y, Igarashi Y, Hakamata Y, Murakami T, Kaneko T, Takahashi M, Seo N, Kobayashi E (2003) Establishment of alb-DsRed2 transgenic rat for liver regeneration research. Biochem Biophys Res Comm 311:478–481PubMedCrossRefGoogle Scholar
  34. Sotomaru Y, Kamisako T, Hioki K (2005) Estrous stage- and animal age-independent superovulation in the BrlHan: WIST@Jcl(GALAS) rat. Exp Anim 54: 137–141PubMedCrossRefGoogle Scholar
  35. Spearow JL, Erickson RP, Edwards T, Herbon L (1991) The effect of H-2 region and genetic background on hormone-induced ovulation rate, puberty, and follicular number in mice. Genet Res 57:41–49PubMedCrossRefGoogle Scholar
  36. Stickrod G (1979) Ketamine/xylazine anesthesia in the pregnant rat. J Am Vet Med Assoc 175:952–953PubMedGoogle Scholar
  37. Swanson ME, Hughes TE, St. Denny I, France DS, Patternitit JR Jr, Tapparelli C, Gfeller P, Bürki K (1992) High level expression of human apolipoprotein A-I in transgenic rats raises total serum high density lipoprotein cholesterol and lowers rat apolipoprotein A-I. Transgenic Res 1:142–147PubMedGoogle Scholar
  38. Tesson L, Cozzi J, Ménoret S, Rémy S, Usal C, Fraichard A, Anegon I (2005) Transgenic modifications of the rat genome. Transgenic Res 14:531–546PubMedCrossRefGoogle Scholar
  39. van den Brandt J, Wang D, Kwon S-H, Heinkelein M, Reichardt HM (2004) Lentivirally generated eGFP-transgenic rats allow efficient cell tracking in vivo. Genesis 39:94–99PubMedCrossRefGoogle Scholar
  40. Vaughan DK, Coulibaly SF, Darrow RM, Organisciak DT (2003) A morphometric study of light-induced damage in transgenic rat models of retinitis pigmentosa. Invest Ophthalmol Vis Sci 44:848–855PubMedCrossRefGoogle Scholar
  41. Vercauteren FG, Clerens S, Roy L, Hamel N, Arckens L, Vandesande F, Alhonen L, Janne J, Szyf M, Cuello AC (2004) Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer’s disease-linked mutations in amyloid precursor protein and presenilin 1. Mol Brain Res 132:241–59PubMedCrossRefGoogle Scholar
  42. Waller SJ, Ho M-Y, Murphy D (1995) Production of transgenic rodents by microinjection of cloned DNA in fertilized one-cell eggs. In: Glover DM and Hames BD (eds) DNA cloning, vol. 4, Oxford University Press, Oxford, pp 184–229Google Scholar
  43. Walton EA, Armstrong DT (1983) Oocyte normality after superovulation in immature rats. J Reprod Fert 67:309–314CrossRefGoogle Scholar
  44. Watson PA, Kim K, Chen KS, Gould MN (2002) Androgen-dependent mammary carcinogenesis in rats transgenic for the Neu proto-oncogene. Cancer Cell 2:67–79PubMedCrossRefGoogle Scholar
  45. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman LB, Wiggins RC (2005) Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16:2941–2952PubMedCrossRefGoogle Scholar
  46. Wisløff U, Najjar SM, Ellingsen ø, Haram PM, Swoap S, Al-Share Q, Fernström M, Rezaei K, Lee SJ, Koch LG, Britton SL (2005) Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 307:418–420PubMedCrossRefGoogle Scholar
  47. Yang XZ, Han MS, Niwa K, Iannaccone PM (2004) Factors required during preculture of rat oocytes soon after sperm penetration for promoting their further development in a chemically defined medium. J Reprod Dev 50:533–540PubMedCrossRefGoogle Scholar
  48. Zhou Y, Galat V, Garton R, Taborn G, Niwa K, Iannaccone P (2003) Two-phase chemically defined culture system for preimplantation rat embryos. Genesis 36:129–133PubMedCrossRefGoogle Scholar
  49. Zucker LM, Zucker TF (1961) Fatty, a new mutation in the rat. J Hered 52:275–278Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2006

Authors and Affiliations

  1. 1.Transgenic Animal Model CoreUniversity of Michigan Medical SchoolAnn ArborUSA
  2. 2.Department of Molecular and Integrative PhysiologyUniversity of Michigan Medical SchoolAnn ArborUSA
  3. 3.Division of Molecular Medicine and Genetics, Department of Internal MedicineUniversity of Michigan Medical SchoolAnn ArborUSA

Personalised recommendations